Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,264
Closed -$805K 71
2021
Q1
$805K Buy
3,264
+140
+4% +$33.4K 0.31% 33
2020
Q4
$718K Sell
3,124
-34
-1% -$7.84K 0.29% 34
2020
Q3
$685K Buy
3,158
+103
+3% +$25.5K 0.32% 25
2020
Q2
$718K Sell
3,055
-42
-1% -$9.58K 0.42% 24
2020
Q1
$626K Buy
3,097
+20
+0.6% +$4.37K 0.37% 27
2019
Q4
$741K Sell
3,077
-18
-0.6% -$3.97K 0.36% 23
2019
Q3
$601K Sell
3,095
-102
-3% -$19.6K 0.31% 29
2019
Q2
$591K Sell
3,197
-174
-5% -$31.2K 0.34% 27
2019
Q1
$640K Sell
3,371
-120
-3% -$22.9K 0.36% 26
2018
Q4
$694K Buy
3,491
+170
+5% +$33.2K 0.42% 22
2018
Q3
$688K Buy
3,321
+17
+0.5% +$3.35K 0.4% 27
2018
Q2
$613K Sell
3,304
-28
-0.8% -$4.95K 0.38% 25
2018
Q1
$566K Buy
3,332
+90
+3% +$16.5K 0.38% 28
2017
Q4
$564K Buy
+3,242
New +$574K 0.44% 24

Other funds holding AMGN

TLWM Financial's AMGN Position: Q2 2021 in Review

TLWM Financial sold out of Amgen (AMGN) in Q2 2021, closing a stake of 3,264 shares — an estimated $805K sold.

TLWM Financial first reported a position in AMGN in Q4 2017 and held it in 14 quarters. The position peaked at $805K in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • TLWM Financial reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • TLWM Financial sold 3,264 Amgen shares in Q2 2021, an estimated $805K.
  • TLWM Financial first reported a position in Amgen in Q4 2017 and held it in 14 quarters.
  • TLWM Financial's Amgen position peaked at $805K in Q1 2021.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on TLWM Financial's 13F filing for Q2 2021, filed 10 Aug 2021.